Zobrazeno 1 - 10
of 2 829
pro vyhledávání: '"Sneller Mc"'
Autor:
Rai MA; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Blazkova J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Justement JS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Shi V; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Kennedy BD; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Manning MR; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., McLaughlin M; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Sneller MC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Pau AK; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Moir S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA., Chun TW; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA. Electronic address: twchun@nih.gov.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Jun; Vol. 104, pp. 105151. Date of Electronic Publication: 2024 May 09.
Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.
Autor:
Pérez-Díez A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Liu X; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Calderon S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Bennett A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Lisco A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Kellog A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Galindo F; Division of Clinical Research, NIAID, NIH, Bethesda, MD, United States., Memoli MJ; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Rocco JM; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Epling BP; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Laidlaw E; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Sneller MC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Manion M; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States., Wortmann GW; Section of Infectious Diseases, MedStar Washington Hospital Center, Washington, DC, United States., Poon R; Division of Hospital Medicine, Georgetown University Medical Center, Washington, DC, United States., Kumar P; Division of Infectious Diseases and Tropical Medicine, Georgetown University Medical Center, Washington, DC, United States., Sereti I; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Apr 17; Vol. 15, pp. 1352330. Date of Electronic Publication: 2024 Apr 17 (Print Publication: 2024).
Autor:
Guinee EP; National Institute of Mental Health, Office of the Clinical Director, 10 Center Drive, NIH Building 10, Room 6-5340, Bethesda, MD 20892, USA., Raza H; National Institute of Mental Health, Office of the Clinical Director, 10 Center Drive, NIH Building 10, Room 6-5340, Bethesda, MD 20892, USA., Ballard ED; National Institute of Mental Health, Experimental Therapeutics & Pathophysiology Branch, NIH Building 10, Room 7-5341, 10 Center Drive, Bethesda, MD 20892., Shaw JS; National Institute of Mental Health, Office of the Clinical Director, 10 Center Drive, NIH Building 10, Room 6-5340, Bethesda, MD 20892, USA., Liang CJ; National Institute of Allergy and Infectious Diseases, Biostatistics Research Branch, 5601 Fishers Lane, Rockville MD 20892., Sneller MC; National Institute of Allergy and Infectious Diseases, Laboratory of Immunoregulation, 10 Center Drive, NIH Building 10, Room 11C103, Bethesda, MD 20892, USA., Chung JY; Office of Clinical Research Training and Medical Education, National Institutes of Health Clinical Center, 10 Center Drive, Room 1N252E, Bethesda, Maryland 20892.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 Jan 22. Date of Electronic Publication: 2024 Jan 22.
Autor:
Fallah MP; Liberia Ministry of Health, Monrovia, Liberia. Electronic address: mfallah1969@gmail.com., Reilly C; Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA., Van Ryn C; Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA., Badio M; Liberia Ministry of Health, Monrovia, Liberia., Camanor SW; John F Kennedy Medical Center, Monrovia, Liberia., Kaler SG; Section on Translational Neuroscience, Molecular Medicine Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA; Center for Gene Therapy, Nationwide Children's Hospital and Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA. Electronic address: stephen.kaler@nationwidechildrens.org., Johnson B; John F Kennedy Medical Center, Monrovia, Liberia., Orone R; ELWA Hospital, Monrovia, Liberia., Flumo H; John F Kennedy Medical Center, Monrovia, Liberia., Moses SJ; John F Kennedy Medical Center, Monrovia, Liberia., Johnson KL; C H Rennie Hospital, Kakata, Liberia., Gorpudolo N; Liberia Ministry of Health, Monrovia, Liberia., Gayedyu-Dennis D; Duport Road Clinic, Paynesville, Liberia., Dighero-Kemp B; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, Fort Detrick, Frederick, MD, USA., Fayiah J; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, Fort Detrick, Frederick, MD, USA., Marron L; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, Fort Detrick, Frederick, MD, USA., Hensley LE; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, Fort Detrick, Frederick, MD, USA., Taylor RJ; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Higgs ES; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Lane HC; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Neaton JD; Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA., Sneller MC; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Publikováno v:
The Lancet. Global health [Lancet Glob Health] 2023 Jul; Vol. 11 (7), pp. e1053-e1060.
Autor:
Gayedyu-Dennis D; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Fallah MP; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.; A.M. Dogliotti College of Medicine, University of Liberia, Monrovia, Liberia., Drew C; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA., Badio M; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA., Moses JS; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA., Fayiah T; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Johnson K; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Richardson ET; Department of Medicine, Brigham and Women's Hospital, Boston, Minnesota, USA.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Minnesota, USA., Weiser SD; Division of HIV, Infectious Disease, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA., Porco TC; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.; Francis I. Proctor Foundation, University of California, San Francisco, California, USA., Martin JN; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA., Sneller MC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA., Rutherford GW; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.; Institute for Global Health Sciences, University of California, San Francisco, California, USA., Reilly C; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA., Lindan CP; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA., Kelly JD; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.; Francis I. Proctor Foundation, University of California, San Francisco, California, USA.; Institute for Global Health Sciences, University of California, San Francisco, California, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2023 Apr 12; Vol. 227 (7), pp. 878-887.
Autor:
Fajnzylber J; Brigham and Women's Hospital, Harvard Medical School., Sharaf R; Brigham and Women's Hospital, Harvard Medical School., Hutchinson JN; Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Aga E; Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Bosch RJ; Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Hartogensis W; University of California, San Francisco, San Francisco, California., Jacobson JM; Case Western Reserve University, Cleveland, Ohio., Connick E; University of Arizona, Tucson, Arizona., Volberding P; University of California, San Francisco, San Francisco, California., Skiest DJ; University of Massachusetts-Baystate, Springfield, Massachusetts., Margolis D; University of North Carolina, Chapel Hill, North Carolina., Sneller MC; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland., Little SJ; University of Caliornia, San Diego, San Diego, California., Gulick RM; Weill Cornell Medicine, New York, New York., Mellors JW; University of Pittsburgh, Pittsburgh, Pennsylvania., Gandhi RT; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Schooley RT; University of Caliornia, San Diego, San Diego, California., Henry K; University of Minnesota, Minneapolis, Minnesota., Tebas P; University of Pennsylvania, Philadelphia, Pennsylvania., Deeks S; University of California, San Francisco, San Francisco, California., Chun TW; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland., Collier AC; University of Washington, Seattle, Washington, USA., Hecht FM; University of California, San Francisco, San Francisco, California., Li JZ; Brigham and Women's Hospital, Harvard Medical School.
Publikováno v:
AIDS (London, England) [AIDS] 2021 Nov 01; Vol. 35 (13), pp. 2225-2227.
Autor:
Sneller MC; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Marques AR; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Liang CJ; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Chung JY; National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland.
Publikováno v:
Annals of internal medicine [Ann Intern Med] 2022 Dec; Vol. 175 (12), pp. W153. Date of Electronic Publication: 2022 Nov 01.
Autor:
Kelly JD; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA; Institute for Global Health Sciences, University of California, San Francisco, CA, USA; F I Proctor Foundation, University of California, San Francisco, CA, USA; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia. Electronic address: dan.kelly@ucsf.edu., Van Ryn C; Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA., Badio M; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Fayiah T; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Johnson K; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Gayedyu-Dennis D; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Weiser SD; Division of HIV, Infectious Disease, and Global Medicine, University of California, San Francisco, CA, USA., Porco TC; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA; F I Proctor Foundation, University of California, San Francisco, CA, USA., Martin JN; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA., Sneller MC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Rutherford GW; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA; Institute for Global Health Sciences, University of California, San Francisco, CA, USA., Reilly C; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia; Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA., Fallah MP; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia; A M Dogliotti College of Medicine, University of Liberia, Monrovia, Liberia., Moses JS; Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Aug; Vol. 22 (8), pp. 1163-1171. Date of Electronic Publication: 2022 May 16.
Autor:
Kardava L; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Rachmaninoff N; Multiscale Systems Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Lau WW; Multiscale Systems Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Buckner CM; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Trihemasava K; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Blazkova J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Lopes de Assis F; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Wang W; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Zhang X; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Wang Y; Institute for Bioscience and Biotechnology Research, Rockville, MD 20850., Chiang CI; Institute for Bioscience and Biotechnology Research, Rockville, MD 20850., Narpala S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., McCormack GE; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Liu C; Multiscale Systems Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Seamon CA; Critical Care Medicine Department, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD 20892., Sneller MC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., O'Connell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Li Y; Institute for Bioscience and Biotechnology Research, Rockville, MD 20850.; Department of Microbiology and Immunology and Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, MD 21201., McDermott AB; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Chun TW; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Fauci AS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Tsang JS; Multiscale Systems Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.; NIH Center for Human Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892., Moir S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Jul 12; Vol. 119 (28), pp. e2204607119. Date of Electronic Publication: 2022 Jun 27.
Autor:
Varughese J, Sneller Mc, Gayedyu-Dennis D, H C Lane, Lisa E. Hensley, Kaylie Tuznik, Kumblytee Johnson, Moses Sj, James D. Neaton, Moses Badio, Cavan S. Reilly, Elizabeth S. Higgs, Rachel Bishop, Kenneth S. Jensen, Allen O. Eghrari, Bonnie Dighero-Kemp, Mosoka Fallah, Avindra Nath
Publikováno v:
The New England journal of medicine. 380(10)
Background Multiple health problems have been reported in survivors of Ebola virus disease (EVD). Attribution of these problems to the disease without a control group for analysis is difficult. Methods We enrolled a cohort of EVD survivors and their